MEGAN BRANDS: Open Payments
NPI 1760003438 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $397 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $57 |
| SANOFI PASTEUR INC. | 1 | $27 |
| Dexcom, Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Corium, LLC | 2 | $15 |
| Amgen Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $13 |
Products named: QULIPTA, UBRELVY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Dexcom G6 Transmitter, RECORLEV, Jornay PM, PROQUAD, Azstarys.
Industry payments across ID — which companies pay providers there.
